← Back to Clinical Trials
Recruiting NCT06526936

NCT06526936 The Effect of Foot Care Training Given to Diabetic Hemodialysis Patients on Foot Care Behavior

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06526936
Status Recruiting
Phase
Sponsor University of Beykent
Condition Diabetic Foot
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2024-06-13
Primary Completion 2025-06-13

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 64 participants in total. It began in 2024-06-13 with a primary completion date of 2025-06-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Diabetic foot causes hospitalization, amputation and serious health problems in individuals. This situation also leads to loss of productivity of the individual, negatively. diabetic foot can be reduced by 85% with good foot care, education and a multidisciplinary team approach. Diabetes is observed in the majority of hemodialysis patients. Foot care becomes even more important if you have more than one chronic disease. The aim of this study is; To determine the effect of "Diabetic foot care training" given to diabetic hemodialysis patients on foot care behavior. The study was planned as a randomized controlled experimental study. It was planned for diabetic hemodialysis patients who were treated in a dialysis center with a study permit.

Eligibility Criteria

Inclusion Criteria: * Being over 18 years old * Having a diagnosis of diabetes * Volunteering to participate in the study * Good communication skills and the patient's ability to receive training himself Exclusion Criteria: * Not willing to participate in conflict

Contact & Investigator

Central Contact

ULKU yılmaz, PHD

✉ ulkyilmz@gmail.com

📞 05346845482

Principal Investigator

ULKU YILMAZ

PRINCIPAL INVESTIGATOR

Istanbul Beykent University

Frequently Asked Questions

Who can join the NCT06526936 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetic Foot. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06526936 currently recruiting?

Yes, NCT06526936 is actively recruiting participants. Contact the research team at ulkyilmz@gmail.com for enrollment information.

Where is the NCT06526936 trial being conducted?

This trial is being conducted at Beylikduzu, Turkey (Türkiye).

Who is sponsoring the NCT06526936 clinical trial?

NCT06526936 is sponsored by University of Beykent. The principal investigator is ULKU YILMAZ at Istanbul Beykent University. The trial plans to enroll 64 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology